Insider · CIK 0002070977
Natasha Fay Thoren
Files at XFOR (X4 Pharmaceuticals, Inc). First filing -, latest -.
In brief
Natasha Fay Thoren files SEC Form 4 as officer at XFOR (X4 Pharmaceuticals, Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Natasha Fay Thoren has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Common Stock | +3,333 | $0.00 | $0 | 9,462 | Jul 3, 2025 |
Questions about Natasha Fay Thoren
Answered from the filings on this page, as of the latest one.
Is Natasha Fay Thoren buying or selling?
Natasha Fay Thoren has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Natasha Fay Thoren's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Natasha Fay Thoren has 0.
Where does Natasha Fay Thoren file Form 4?
Natasha Fay Thoren has filed Form 4 at XFOR (X4 Pharmaceuticals, Inc) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.